MacroBID® now Pharmac funded on the PSO
Updated: July 1, 2022 PHARMAC has now implemented widened funded access to the first line UTI treatment MacroBID® modified release...
MacroBID® now Pharmac funded on the PSO
Medsafe Approves Trientine Tetrahydrochloride (Cuprior) for the Treatment Of Wilson's Disease
PHARMAC funds new medicine MacroBID®